Momat ointment 15g

Ointment for external use

Composition

100 mg contain mometasone furoate 0.1 g;
excipients: paraffin (soft, white); beeswax white; propylene glycol monostearate.

Packing

15

Mechanism of action

Momat-S has a glucocorticoid, anti-inflammatory, anti-allergic, anti-exudative, antipruritic effect.

Indications and usage

Psoriasis, atopic dermatitis and other dermatoses, incl. in the area of ​​the scalp; allergic rhinitis, seasonal and chronic (treatment and prevention).

Contraindications

Hypersensitivity, pregnancy and lactation, child age (up to 12 years).

Dosage and administration

Externally, apply a thin layer on the affected skin once a day. The duration of the course of treatment is determined by its efficacy, as well as the tolerability of the patient, the presence and severity of side effects.

Adverse reactions

Burning, itching, tingling and tingling, paresthesia, folliculitis, acne-like rashes, skin atrophy, hypertrichosis, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, secondary infection, striae, strep.

Special notes

Appropriate precautions should be taken when applying ointment to large areas of the skin or intended long-term use (especially when used in pediatrics). Due to the fact that the ratio of skin surface and body weight in children is higher than in adults, children may show higher sensitivity to the action of GCS than adults, with the appearance of signs of suppression of the hypothalamic-pituitary-adrenal system and the manifestation of Cushing's syndrome. Ointment is not recommended for use with occlusive dressings, including diapers and diapers. The drug is not intended for use on the face or in the groin and axilla areas. Ointment is not to be used in ophthalmology. Children should receive the minimum amount of corticosteroids necessary to achieve the effect. Prolonged therapy with SCS may have an undesirable effect on the growth and development of children. In case of irritation, incl. excessive dryness of the skin and with the appearance of allergic reactions, you should stop using the drug Momat-S and prescribe the appropriate treatment. If concomitant skin infection develops, the necessary antifungal or antibacterial agent should be used. If a positive response to treatment is not achieved quickly, the use of Momat-C should be interrupted until the infection is properly eliminated.It is necessary to assess the risk and the expected effect of the use of the drug Momat-C in case of the following diseases: diabetes mellitus, damage or inflammation of peripheral vessels, irritation or infection of the skin. GCS can cause a change in the appearance of the affected skin, making it difficult to make a correct diagnosis and leads to slower recovery.

Drug Interactions

With the local use of the drug Momat-C, the presence of very small, but measurable amounts of salicylates in the blood plasma was observed. According to published data on the interaction of salicylates with other substances after ingestion or application to the skin, it is possible to change the effect of the following medicinal compounds: tolbutamide (butamide), Methotrexate, Heparin, pyrazinamide, agents that promote the excretion of uric acid, and preparations of indirect anticoagulants. Other corticosteroids and ammonium sulfate can affect salicylic acid content. These interactions should be borne in mind when prescribing the drug Momat-C together with these compounds.

Overdosage

Prolonged use of GCS for topical use in excessive amounts can lead to suppression of the hypothalamic-pituitary-adrenal system and secondary adrenal insufficiency. If suppression of the hypothalamic-pituitary-adrenal system is observed, then the use of the ointment should be discontinued or the frequency of application should be reduced.In the case of toxicity caused by salicylic acid, the use of the drug Momat-C should be discontinued. To stimulate the output of salicylates in the urine should be injected fluids. As necessary, you can assign oral or in / in the introduction of sodium bicarbonate and potassium salts.

Storage conditions

In the dark place at a temperature of no higher than 25 ° C.

2 years.